Current Vascepa Coupon Options
Vascepa (icosapent ethyl) coupons from manufacturers and pharmacies often cut copays to $0-$30 for eligible commercially insured patients, with savings cards valid through 2025 or later. Check these active offers:
- Manufacturer Savings Card: Amarin provides a card reducing out-of-pocket costs to as low as $9 per fill (up to 12 fills/year, max $7,080 savings). Available at GetVascepaSavings.com; requires commercial insurance, not valid for government plans like Medicare.[1]
- GoodRx Discounts: Prices start at $250-$300 for 120 capsules (lowest at Costco or Walmart), a 20-30% drop from retail $400+ without insurance. No eligibility rules; print or app-based.[2]
- SingleCare or RxSaver: Similar to GoodRx, offers from $260 per fill; stackable with some insurance but check pharmacy rules.[3]
Who Qualifies and Restrictions
Eligibility typically needs commercial insurance (not Medicare/Medicaid). Household income limits apply for some patient assistance programs. Cards expire or reset annually; track usage via app portals. Pharmacies like CVS or Walgreens honor most digitally.
Vascepa Patient Assistance Programs
Uninsured or underinsured patients can apply for free or low-cost Vascepa through Amarin's CARE Program (vascepacarepath.com). Income-based (up to 400% FPL), covers full-year supply after approval in days.[4] Cosentyx-like bridge programs offer starter doses during prior authorizations.
How to Get and Use Coupons
Download from GetVascepaSavings.com or GoodRx.com, show digitally at pharmacy. Activation takes 2 minutes online. For 140 mg or 1g doses, confirm pricing matches your script. Combine with 90-day fills for max savings.
Cheaper Alternatives to Vascepa
- Generic Icosapent Ethyl: Available since 2020 at $100-$200/month via GoodRx, same active ingredient.[5]
- Lovaza (prescription omega-3): $150-$250 with coupons, but different formulation.[6]
- OTC Fish Oil: $10-$20/month, lower EPA purity; not FDA-approved for Vascepa's cardio uses.
Why Prices Vary and Patent Status
Vascepa faces generic competition after key patents expired (e.g., 2020 method-of-use). Ongoing litigation with Hikma and others delays full generics until 2026-2030 for some claims. Check DrugPatentWatch.com for expiry details and challengers.7
[1]: https://www.getvascepasavings.com/
[2]: https://www.goodrx.com/vascepa
[3]: https://www.singlecare.com/prescription/vascepa
[4]: https://www.vascepacarepath.com/
[5]: https://www.goodrx.com/icosapent-ethyl
[6]: https://www.goodrx.com/lovaza